In the process of exerting respective therapeutic effects, the side effects of anti-PD-1/PD-L pathway are mostly reported as dermatologic toxicity, gastrointestinal toxicity, endocrinopathies, pneumonitis and rheumatologic toxicity (14). The gene discussed is PDCD1; the disease is pneumonitis.